Published in Infect Immun on January 01, 2002
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Clin Exp Immunol (2004) 1.54
VNTR analysis reveals unexpected genetic diversity within Mycoplasma agalactiae, the main causative agent of contagious agalactia. BMC Microbiol (2008) 0.85
Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes. Curr HIV Res (2008) 0.85
Development of a sensitive and specific enzyme-linked immunosorbent assay based on recombinant antigens for rapid detection of antibodies against Mycoplasma agalactiae in sheep. Clin Vaccine Immunol (2007) 0.82
An Introduction to B-Cell Epitope Mapping and In Silico Epitope Prediction. J Immunol Res (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev (1998) 7.89
In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem (1992) 6.44
Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol (1982) 5.52
Conformational preferences of amino acids in globular proteins. Biochemistry (1978) 4.00
The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol (1968) 2.75
Adaptive surface variation in mycoplasmas. Trends Microbiol (1993) 2.05
Contagious agalactia of small ruminants: current knowledge concerning epidemiology, diagnosis and control. Rev Sci Tech (1997) 1.77
Molecular basis of size and antigenic variation of a Mycoplasma hominis adhesin encoded by divergent vaa genes. Infect Immun (1996) 1.76
Identification and characterization of a Mycoplasma hyopneumoniae adhesin. Infect Immun (1995) 1.68
Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae. Infect Immun (2000) 1.48
Mycoplasma synoviae has two distinct phase-variable major membrane antigens, one of which is a putative hemagglutinin. Infect Immun (1997) 1.26
The vsp locus of Mycoplasma bovis: gene organization and structural features. J Bacteriol (1999) 1.22
Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins. Infect Immun (2000) 1.16
The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur J Immunol (1992) 1.01
Comparison of Mycoplasma agalactiae isolates by pulsed field gel electrophoresis, SDS-PAGE and immunoblotting. FEMS Microbiol Lett (1996) 0.99
Mechanisms and factors involved in Mycoplasma bovis adhesion to host cells. Zentralbl Bakteriol (1996) 0.96
Rapid and specific detection of Mycoplasma agalactiae by polymerase chain reaction. Vet Microbiol (1996) 0.93
A chromosomal region of Mycoplasma agalactiae containing vsp-related genes undergoes in vivo rearrangement in naturally infected animals. FEMS Microbiol Lett (2000) 0.92
Characterization of membrane surface proteins of Mycoplasma agalactiae during natural infection. FEMS Microbiol Lett (1997) 0.87
Experimental vaccination against Mycoplasma agalactiae using different inactivated vaccines. Vaccine (1999) 0.83
Contagious agalactia of sheep and goats studies on live and dead vaccines in lactating sheep. J Comp Pathol (1971) 0.82
Contagious agalactia of sheep and goats. Immunity of lactating ewes vaccinated before mating with live or dead vaccines. J Comp Pathol (1971) 0.79
Recovery of Mycoplasma agalactiae from mastitic goat milk. J Am Vet Med Assoc (1983) 0.79
Persistence of antibodies to Mycoplasma agalactiae in vaccinated sheep. New Microbiol (1998) 0.78
Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem (2005) 1.23
Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions. Autoimmun Rev (2008) 1.16
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis (2008) 1.14
Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem J (2009) 1.08
Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress. Free Radic Biol Med (2010) 1.06
In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica (2004) 0.98
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases. Melanoma Res (2005) 0.97
Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications. Transfus Med Hemother (2012) 0.97
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth. Proteomics (2010) 0.97
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics (2008) 0.96
Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J Proteomics (2009) 0.96
Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells. PLoS One (2011) 0.95
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3. Free Radic Biol Med (2012) 0.90
Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma. Virchows Arch (2007) 0.89
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis. Haematologica (2011) 0.86
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease. Blood Cells Mol Dis (2010) 0.86
Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. J Neurochem (2007) 0.85
Mechanisms of band 3 oxidation and clustering in the phagocytosis of Plasmodium falciparum-infected erythrocytes. Redox Rep (2003) 0.84
Characterization of the protein ubiquitination response induced by Doxorubicin. FEBS J (2012) 0.84
Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies. Anal Biochem (2005) 0.83
New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation. Free Radic Biol Med (2011) 0.81
Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells. PLoS One (2011) 0.81
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial. PLoS One (2009) 0.81
Acrylamide-agarose copolymers: improved resolution of high molecular mass proteins in two-dimensional gel electrophoresis. Proteomics (2005) 0.80
Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase. Haematologica (2013) 0.80
Bcl2-A1 interacts with pro-caspase-3: implications for amyotrophic lateral sclerosis. Neurobiol Dis (2011) 0.79
Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: Evidence from transgenic sickle cell mouse model. Proteomics Clin Appl (2008) 0.79
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques. Clin Biochem (2009) 0.79
Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxid Med Cell Longev (2013) 0.78
Effect of heterozygous beta thalassemia on the phosphorylative response to Plasmodium falciparum infection. J Proteomics (2012) 0.76
May band 3 hyper-phosphorylation have a functional role in microcyte formation in heterozygous thalassemias? Blood Cells Mol Dis (2010) 0.76
Performance of a novel sieving matrix of poly(vinyl alcohol)/acrylamide copolymer in electrophoretic separations of high molecular weight proteins from red cell membrane. Electrophoresis (2014) 0.75
Immunohistochemical and proteomic profile of melanotic medulloblastoma. Pediatr Blood Cancer (2009) 0.75
Characterization of sodium dodecylsulfate polyacrylamide gel electrophoresis-separated M. agalactiae membrane antigens by mass spectrometry. Eur J Mass Spectrom (Chichester, Eng) (2004) 0.75